Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Everolimus
×
Lymphoid
×
Clear all
Filters
3
NCT02113800
2020-10-28
EVINEC
AIO-Studien-gGmbH
Phase 2
Completed
40 enrolled